Value
8.4/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 8.2 |
| P/S | 8.8 |
| EV/EBITDA | 7.5 |
| Fwd P/E | 9.9 |
| PEG | 10.0 |
| Analyst target | 6.0 |
- ▸Forward P/E: 5.9x
- ▸PEG: 0.04
- ▸Attractively valued
HRMY · Why this verdict
Why Harmony Biosciences Holdings, I (HRMY) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score7.0/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
A business with a wide economic moat, a Piotroski score of 9 out of 9, and 16% margins trades at a forward multiple of 6.1x with a PEG of 0.05 — implying the market is deeply discounting a franchise with durable return characteristics; the setup is held back by three earnings misses in the last four quarters and a sole-product revenue base that amplifies any execution stumble.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The business earns strong returns with 16% margins, carries a Piotroski score of 9 out of 9, and is assessed as having a wide economic moat — yet the market prices it at a forward P/E of 6.1x and a PEG of 0.05, a valuation that appears to leave considerable earnings power unrecognized. Quality breakdown | If the quality advantage is real and durable, the forward earnings multiple should expand toward a mid-teens range over 12 months as the market re-rates the franchise on normalized earnings. | →Stable |
| CounterThree of the last four quarters missed consensus estimates; if the underlying earnings trajectory is genuinely deteriorating rather than temporarily disrupted, a single-digit forward multiple may be precisely correct rather than undervalued. | ||
All commercial revenue flows through a single product, and the manufacturing base depends on sole-source suppliers and manufacturers, leaving no buffer if that one revenue stream faces a demand, pricing, or supply interruption. Bear case | If this risk is not realized, product revenue should grow without any supply interruption and management should maintain or improve manufacturing redundancy disclosures over the next year. | →Stable |
| CounterSole-product franchises often achieve dominant market share and strong pricing control within their niche; if market penetration continues to expand, concentration reflects competitive strength rather than structural fragility. | ||
The two most recent quarters each missed consensus — by 16% and 46% respectively — and three of the last four quarters have come in below estimates, producing an average earnings surprise of negative 10% and raising questions about whether guidance discipline has slipped. Earnings | If this concern is misplaced, earnings should beat or meet consensus in at least two of the next three reported quarters, with positive guidance revisions following. | ↑Improving |
| CounterThe one beat in this period was a 25% upside surprise, and the earnings growth score stands at the top of its range; the misses may reflect lumpy, hard-to-forecast revenue rather than a structural downshift in profitability. | ||
At the current price, the reward-to-risk geometry produces a ratio near 1-to-1 — below the 1.5-to-1 threshold required to justify a new position — meaning an investor captures roughly $1 of upside for every $1 of downside accepted. Engine gate (failed) | For this pillar to resolve favorably, the reward-to-risk ratio should rise above 1.5 to 1 — either through a price pullback or through an upward revision to analyst targets — before the setup becomes actionable. | Tripped→Stable |
| CounterAnalyst consensus targets imply 30% upside from current levels; if execution stabilizes and momentum follows, the current geometry may represent a temporary dislocation rather than a permanent feature of the setup. | ||
The business earns strong returns with 16% margins, carries a Piotroski score of 9 out of 9, and is assessed as having a wide economic moat — yet the market prices it at a forward P/E of 6.1x and a PEG of 0.05, a valuation that appears to leave considerable earnings power unrecognized.
→StableQuality breakdown
- Expectation
- If the quality advantage is real and durable, the forward earnings multiple should expand toward a mid-teens range over 12 months as the market re-rates the franchise on normalized earnings.
CounterThree of the last four quarters missed consensus estimates; if the underlying earnings trajectory is genuinely deteriorating rather than temporarily disrupted, a single-digit forward multiple may be precisely correct rather than undervalued.
All commercial revenue flows through a single product, and the manufacturing base depends on sole-source suppliers and manufacturers, leaving no buffer if that one revenue stream faces a demand, pricing, or supply interruption.
→StableBear case
- Expectation
- If this risk is not realized, product revenue should grow without any supply interruption and management should maintain or improve manufacturing redundancy disclosures over the next year.
CounterSole-product franchises often achieve dominant market share and strong pricing control within their niche; if market penetration continues to expand, concentration reflects competitive strength rather than structural fragility.
The two most recent quarters each missed consensus — by 16% and 46% respectively — and three of the last four quarters have come in below estimates, producing an average earnings surprise of negative 10% and raising questions about whether guidance discipline has slipped.
↑ImprovingEarnings
- Expectation
- If this concern is misplaced, earnings should beat or meet consensus in at least two of the next three reported quarters, with positive guidance revisions following.
CounterThe one beat in this period was a 25% upside surprise, and the earnings growth score stands at the top of its range; the misses may reflect lumpy, hard-to-forecast revenue rather than a structural downshift in profitability.
At the current price, the reward-to-risk geometry produces a ratio near 1-to-1 — below the 1.5-to-1 threshold required to justify a new position — meaning an investor captures roughly $1 of upside for every $1 of downside accepted.
Tripped→StableEngine gate (failed)
- Expectation
- For this pillar to resolve favorably, the reward-to-risk ratio should rise above 1.5 to 1 — either through a price pullback or through an upward revision to analyst targets — before the setup becomes actionable.
CounterAnalyst consensus targets imply 30% upside from current levels; if execution stabilizes and momentum follows, the current geometry may represent a temporary dislocation rather than a permanent feature of the setup.
Per-dimension breakdown
Quality
7.8/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 6.0 |
| ROA | 6.8 |
| Gross margin | 10.0 |
| Op margin | 6.9 |
| Net margin | 8.1 |
| Current ratio | 9.4 |
| FCF quality | 7.1 |
| Moat | 8.4 |
| Rule of 40 | 5.5 |
| Piotroski F | 10.0 |
- ▸Strong margins: 16%
- ▸Wide economic moat
- ▸Compounder quality: strong returns + growth
- ▸Strong Piotroski F-Score: 9/9
Growth
8.3/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 6.7 |
| EPS growth | 10.0 |
Momentum
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 2.3 |
| OBV | 10.0 |
| MA position | 6.0 |
| Volume | 3.6 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
7.7/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 7.8 |
| Analyst rating | 7.0 |
| Price target | 8.4 |
- ▸LLM news sentiment: +0.55 (n=1)
- ▸Light analyst coverage (10.0) — signal dampened
- ▸Analyst upside: 28%
Insider
7.3/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
- ▸Institutions accumulating
Peer rank
6.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 7.8 |
| quality rank | 7.9 |
| growth rank | 5.3 |
- ▸Superior ROE vs peers
Technical
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 5.2 |
| support resistance | 5.0 |
| 52w position | 7.4 |
| gap | 5.0 |
Risk (lower is worse)
5.0/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 4.1 |
| days to cover | 4.0 |
| volatility | 2.1 |
| put call | 7.8 |
| implied vol | 0.0 |
| beta | 7.4 |
| debt equity | 9.3 |
- ▸High IV: 89%
- ▸Concentration risks: 3 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
3.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 0.0 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
| news activity | 5.0 |
- ▸Earnings concerns: 1B/3M
- ▸Earnings in 0 days
How the verdict was assembled
Engine trigger
Earnings in 0 days. Wait until post-earnings.
Engine technical detail
verdict_path:
L3:NEWS_BLOCK|ENTRY_STICKY:WITHIN_BANDPassed (5)
- MOMENTUM:5.5>=4.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- ASYMMETRY:1.2<1.5@spot
- EARNINGS_PROXIMITY:0d<=7d
Warning (2)
- MOMENTUM:5.5<5.5 (soft — BUY_NOW allowed but watch)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
1.19
Upside
+11.2%
Downside
9.4%
Sizing output
STARTER
SetupRange Bound — RSI 54 mid-range, Bollinger mid-band
EdgeNo clear edge — No clear edge identified
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
A recent news event triggered an L3 news-block on the verdict path. Trigger: Earnings in 0 days. Wait until post-earnings. The 10-dimension scores remain Value at 8.4 (strongest), but ASYMMETRY:1.2<1.5@spot also fails — the news block is the proximate trigger, not the sole driver.
The strongest dimensions are Value at 8.4, Growth at 8.3, and Quality at 7.8; the weakest are Catalyst at 3.0, Risk (lower is worse) at 5.0, and Momentum at 5.5. The V9 engine flagged 2 failed gates with 2 warnings, producing an asymmetric reward-to-risk of 1.19 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Wide Moat Bargain Valuation
Trip ifGross margin falls below 12% from the current 16% for 2 consecutive quarters.
- P2Earnings Miss Pattern Risk
Trip ifEPS beats consensus by more than 5% in 2 of the next 3 reported quarters.
- P3Single Product Sole Source Concentration
Trip ifA second commercial product contributes more than 20% of total quarterly revenue for 2 consecutive quarters.
- P4Asymmetry Too Thin At SpotTripped
Trip ifReward-to-risk ratio rises above 1.5 as the share price falls to $31 or analyst price targets are revised above $45.